COMMUNIQUÉS West-GlobeNewswire

Akcea Reports Financial Results and Highlights for Second Quarter 2019
06/08/2019
Achieved Second Quarter 2019 TEGSEDI ® (inotersen) Global Net Product Revenues of $10 Million Conference Call Webcast Tuesday, August 6, 4:30 p.m. ET at www.akceatx.com BOSTON, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Akcea [...]
Chembio Diagnostics Reports Second Quarter 2019 Financial Results
06/08/2019
MEDFORD, N.Y., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial results for the quarter [...]
Paratek Pharmaceuticals Generates Net Revenues of $2.0 Million in the Second Quarter of 2019
06/08/2019
-- NUZYRA ® (omadacycline) Net Sales increased 26% to $1.7 Million in the Second Quarter of 2019 -- -- Over 50% of Commercial Lives in U.S. now have Access to NUZYRA -- -- Paratek Promotes Evan Loh, M.D. to Chief [...]
Codexis Names Ross Taylor Senior Vice President and Chief Financial Officer
06/08/2019
CFO Gordon Sangster announces retirement REDWOOD CITY, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces the appointment of Ross Taylor as Senior [...]
IRIDEX Announces 2019 Second Quarter Financial Results
06/08/2019
MOUNTAIN VIEW, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the second quarter ended June 29, 2019. Second Quarter Highlights Total revenue of $10.4 [...]
Forty Seven Inc. to Report Second Quarter 2019 Financial Results on Tuesday, August 13, 2019
06/08/2019
MENLO PARK, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Forty Seven Inc. (NASDAQ:FTSV), a clinical-stage, immuno-oncology company focused on developing therapies to activate macrophages in the fight against cancer, today [...]
PhaseBio To Report Second Quarter 2019 Financial Results and Recent Corporate Progress on August 13, 2019
06/08/2019
MALVERN, Pa. and SAN DIEGO, Aug. 06, 2019 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies [...]
Zogenix Provides Corporate Update and Reports Second Quarter 2019 Financial Results
06/08/2019
Agreement reached with U.S. FDA for resubmission of NDA for FINTEPLA® for the treatment of Dravet syndrome; resubmission expected in September Enrollment complete for FINTEPLA global Phase 3 trial in Lennox Gastaut [...]
Retrophin Reports Second Quarter 2019 Financial Results
06/08/2019
Top-line results from pivotal Phase 3 FORT Study in PKAN on-track for 3Q 2019 Commercial launch for THIOLA ® EC underway following FDA-approval for the treatment of cystinuria Second quarter revenues increased eight [...]
Editas Medicine Appoints Cynthia Collins as President and Chief Executive Officer
06/08/2019
CAMBRIDGE, Mass., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that its Board of Directors has unanimously appointed Cynthia (Cindy) Collins, [...]
Axogen, Inc. Reports 2019 Second Quarter Financial Results
06/08/2019
Second Quarter Revenue of $26.7 million, Representing 30% Growth Versus Second Quarter 2018 ALACHUA, Fla., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing [...]
Cambrex to Announce Second Quarter 2019 Financial Results on August 9, 2019
06/08/2019
EAST RUTHERFORD, N.J., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug [...]
The Spanish Sarcoma Group Will Lead a European Consortium to Evaluate the Ability of Lixte Biotechnology Holdings’ LB-100 to Improve First Line Therapy for Advanced Soft Tissue Sarcomas
06/08/2019
EAST SETAUKET, NY, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. ( OTCQB: LIXT ) announced that it signed a clinical trial agreement with the Spanish Sarcoma Group (Grupo Español de Investigación [...]
The Spanish Sarcoma Group Will Lead a European Consortium to Evaluate the Ability of Lixte Biotechnology Holdings’ LB-100 to Improve First Line Therapy for Advanced Soft Tissue Sarcomas
06/08/2019
EAST SETAUKET, N.Y., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. ( OTCQB: LIXT ) announced that it signed a clinical trial agreement with the Spanish Sarcoma Group (Grupo Español de [...]
Smart Decision, Inc., is Now Patent Pending for Automated CBD Product Recommendation System and Method
06/08/2019
Boca Raton, FL, Aug. 06, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Smart Decision, Inc. (OTC Pink Markets: SDEC), a next-generation consumer-based LED & CBD algorithm innovator, is pleased to announce that it has [...]
Predictive Technology Group Names Industry Veteran Dr. E. Robert Wassman Co-Laboratory Director of Predictive Laboratories
06/08/2019
Dr. Wassman brings 35 years of genetics diagnostic and personalized medicine experience, and significant expertise to lead the cytogenetics section of Predictive Laboratories SALT LAKE CITY, Aug. 06, 2019 (GLOBE [...]
NuMe TMS Clinics Now Offer FDA-Cleared Treatment for Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD) in Houston
06/08/2019
NuMe TMS Clinics’ Houston location joins mental health practices around the country providing access to BrainsWay’s Deep Transcranial Magnetic Stimulation (Deep TMS) therapy for MDD and OCD HOUSTON, Aug. 06, 2019 (GLOBE [...]
Cerner, Duke Clinical Research Institute Launch New Solution to Innovate Clinical Research
06/08/2019
The Cerner Learning Health Network to Transform Research Data Collection and Application In the Care Setting KANSAS CITY, Mo., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq: CERN), a global health [...]
AXIM® Biotechnologies Featured in Bloomberg Law for Robust Cannabinoid-Based Patent Portfolio
06/08/2019
NEW YORK, Aug. 06, 2019 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTC: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), a world leader in cannabinoid research and product development, today announced that it has [...]

Pages